Karen J. Howie

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.

Journal: Lung

Published: June 12, 2026

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Journal: Chest

Published: March 31, 2026

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Journal: ERJ open research

Published: February 18, 2026

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Journal: The European respiratory journal

Published: January 19, 2026

Pathobiology of atopic dermatitis and association with disease severity after acute oral steroid treatment.

Pathobiology of atopic dermatitis and association with disease severity after acute oral steroid treatment.

Journal: The journal of allergy and clinical immunology. Global

Published: October 07, 2025

Monocyte Chemotactic Factors in the Airways of Patients With Mild Asthma Before and After an Allergen Challenge.

Monocyte Chemotactic Factors in the Airways of Patients With Mild Asthma Before and After an Allergen Challenge.

Journal: Allergy

Published: August 29, 2025

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial.

Journal: The European respiratory journal

Published: July 28, 2025

Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma.

Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma.

Journal: Clinical and translational allergy

Published: June 10, 2025

Predicting airway hyperresponsiveness to methacholine in patients with atopic dermatitis.

Predicting airway hyperresponsiveness to methacholine in patients with atopic dermatitis.

Journal: The journal of allergy and clinical immunology. Global

Published: June 06, 2025

Benralizumab Depletes IL-5Rα-Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis.

Benralizumab Depletes IL-5Rα-Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis.

Journal: Clinical and translational allergy

Published: December 29, 2024

Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.

Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial.

Journal: Nature communications

Published: September 28, 2024

Mannitol-evoked cough response is reduced by inhaled salbutamol.

Mannitol-evoked cough response is reduced by inhaled salbutamol.

Journal: ERJ open research

Published: August 26, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026